Ali Rezaei Mokarram

427 total citations
15 papers, 307 citations indexed

About

Ali Rezaei Mokarram is a scholar working on Molecular Biology, Pharmaceutical Science and Infectious Diseases. According to data from OpenAlex, Ali Rezaei Mokarram has authored 15 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Pharmaceutical Science and 3 papers in Infectious Diseases. Recurrent topics in Ali Rezaei Mokarram's work include Advanced Drug Delivery Systems (6 papers), RNA Interference and Gene Delivery (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Ali Rezaei Mokarram is often cited by papers focused on Advanced Drug Delivery Systems (6 papers), RNA Interference and Gene Delivery (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Ali Rezaei Mokarram collaborates with scholars based in Iran and United States. Ali Rezaei Mokarram's co-authors include Khosrow Aghaiypour, Massoud Saidijam, Elham Bahreini, Roghayeh Abbasalipourkabir, Mohammad Taghi Goodarzi, Ali Es‐haghi, Majid Soleimani, Marı́a José Alonso, Mosadegh Keshavarz and Majid Tebianian and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Nanoscale Research Letters.

In The Last Decade

Ali Rezaei Mokarram

15 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Rezaei Mokarram Iran 9 110 79 54 48 42 15 307
María Julia Altube Argentina 11 110 1.0× 92 1.2× 32 0.6× 50 1.0× 16 0.4× 16 327
Maria Vittoria Mauro Italy 11 76 0.7× 44 0.6× 35 0.6× 28 0.6× 62 1.5× 33 396
Ganesh Yadagiri India 12 106 1.0× 87 1.1× 37 0.7× 136 2.8× 36 0.9× 27 368
Alhanouf I. Al-Harbi Saudi Arabia 11 171 1.6× 67 0.8× 46 0.9× 72 1.5× 36 0.9× 21 540
Riham M. El‐Moslemany Egypt 15 146 1.3× 211 2.7× 84 1.6× 127 2.6× 25 0.6× 27 616
Sixiang Sai China 8 80 0.7× 106 1.3× 43 0.8× 46 1.0× 75 1.8× 14 278
Upendra P. Lambe India 8 80 0.7× 43 0.5× 90 1.7× 19 0.4× 74 1.8× 16 350
Vinay Kumar Venishetty India 7 144 1.3× 159 2.0× 99 1.8× 45 0.9× 19 0.5× 15 428
Shabi Parvez India 10 104 0.9× 81 1.0× 56 1.0× 84 1.8× 15 0.4× 16 298
Marta Silva Portugal 7 120 1.1× 44 0.6× 34 0.6× 10 0.2× 44 1.0× 9 301

Countries citing papers authored by Ali Rezaei Mokarram

Since Specialization
Citations

This map shows the geographic impact of Ali Rezaei Mokarram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Rezaei Mokarram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Rezaei Mokarram more than expected).

Fields of papers citing papers by Ali Rezaei Mokarram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Rezaei Mokarram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Rezaei Mokarram. The network helps show where Ali Rezaei Mokarram may publish in the future.

Co-authorship network of co-authors of Ali Rezaei Mokarram

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Rezaei Mokarram. A scholar is included among the top collaborators of Ali Rezaei Mokarram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Rezaei Mokarram. Ali Rezaei Mokarram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Mehrabadi, Mohammad Hossein Fallah, Ali Es‐haghi, Saeed Kalantari, et al.. (2024). Safety and Immunogenicity of Intranasal Razi Cov Pars as a COVID-19 Booster Vaccine in Adults: Promising Results from a Groundbreaking Clinical Trial. Vaccines. 12(11). 1255–1255. 2 indexed citations
2.
Es‐haghi, Ali, Mohammad Hossein Fallah Mehrabadi, Ali Rezaei Mokarram, et al.. (2022). Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models. Frontiers in Immunology. 13. 836745–836745. 27 indexed citations
3.
Hedayati, Mojtaba, et al.. (2019). Diphtheria toxoid nanoparticles improve learning and memory impairment in animal model of Alzheimer’s disease. Pharmacological Reports. 72(4). 814–826. 13 indexed citations
4.
Kalantar, Seyed Mehdi, Ali Rezaei Mokarram, Meghdad Abdollahpour‐Alitappeh, et al.. (2019). Bordetella pertussis antigens encapsulated into N-trimethyl chitosan nanoparticulate systems as a novel intranasal pertussis vaccine. Artificial Cells Nanomedicine and Biotechnology. 47(1). 2605–2611. 21 indexed citations
5.
Nejabat, Mahmood, et al.. (2019). Effects of intranasal administration of violet oil in dry eye disease. Clinical and Experimental Optometry. 102(6). 576–582. 6 indexed citations
6.
Soleimani, Majid, et al.. (2018). Synergistic co-delivery of doxorubicin and melittin using functionalized magnetic nanoparticles for cancer treatment: loading and in vitro release study by LC–MS/MS. Artificial Cells Nanomedicine and Biotechnology. 46(sup3). 1226–1235. 44 indexed citations
7.
8.
Bahreini, Elham, Khosrow Aghaiypour, Roghayeh Abbasalipourkabir, et al.. (2014). Preparation and nanoencapsulation of l-asparaginase II in chitosan-tripolyphosphate nanoparticles and in vitro release study. Nanoscale Research Letters. 9(1). 340–340. 97 indexed citations
9.
Amini, Mohammad, et al.. (2013). Foot and Mouth Disease virus-loaded fungal chitosan nanoparticles for intranasal administration: impact of formulation on physicochemical and immunological characteristics. Pharmaceutical Development and Technology. 19(3). 333–341. 8 indexed citations
10.
Dehghani, Fatemeh, Mostafa Haji Molla Hoseini, Arash Memarnejadian, et al.. (2011). Immunomodulatory Activities of Chitin Microparticles on Leishmania major-infected Murine Macrophages. Archives of Medical Research. 42(7). 572–576. 20 indexed citations
11.
12.
Mokarram, Ali Rezaei, et al.. (2010). Preparation and in-vitro evaluation of indomethacin nanoparticles.. PubMed. 18(3). 185–92. 23 indexed citations
13.
14.
15.
Mortazavi, Seyed Alireza & Ali Rezaei Mokarram. (2004). PREPARATION AND EVALUATION OF DIPHTHERIA TOXOID-CONTAINING MICROSPHERES. Iranian journal of pharmaceutical research. 3(3). 133–143. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Julia Altube Breakdown of academic impact, for papers by Maria Vittoria Mauro Breakdown of academic impact, for papers by Ganesh Yadagiri Breakdown of academic impact, for papers by Alhanouf I. Al-Harbi Breakdown of academic impact, for papers by Riham M. El‐Moslemany Breakdown of academic impact, for papers by Sixiang Sai Breakdown of academic impact, for papers by Upendra P. Lambe Breakdown of academic impact, for papers by Vinay Kumar Venishetty Breakdown of academic impact, for papers by Shabi Parvez Breakdown of academic impact, for papers by Marta Silva
Rankless by CCL
2026